U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9858198581Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA.CompletedNo Results AvailableHIV InfectionDrug: TMC278LA|Drug: TMC278LA|Drug: TMC278LA|Drug: TMC278LAhttps://ClinicalTrials.gov/show/NCT01275443
9858298582Assessment of the Precision of the Sherlock 3CG Tip Positioning SystemTerminatedNo Results AvailablePeripherally Inserted Central CathetersDevice: Sherlock 3CG|Other: Blind Placementhttps://ClinicalTrials.gov/show/NCT01275430
9858398583Using Different Kinds of B-cun Scales to Mark Some Acupoints at Governor Vessel on the HeadCompletedNo Results Availableto Research the Feasibility of the Proportional Bone(Skeletal) Measurement Method on the Head Region.https://ClinicalTrials.gov/show/NCT01275417
9858498584Therapy for Erectile Dysfunction Adaptation of ACT for Compliance With an Erectile Rehabilitation ProgramActive, not recruitingNo Results AvailableProstate CancerBehavioral: Sexual Medicine Rehabilitation Program + nurse practitioner information phone calls|Behavioral: Sexual Medicine Rehabilitation Program + Acceptance and Commitment Therapy for Erectile Dysfunctionhttps://ClinicalTrials.gov/show/NCT01275404
9858598585cSBIRT to Reduce Teen Tobacco, Alcohol and Drug UseWithdrawnNo Results AvailableTobacco Use|Alcohol Abuse|Drug AbuseBehavioral: Computer Screening, Brief Intervention, Referral toTreatmenthttps://ClinicalTrials.gov/show/NCT01275391
9858698586Comparative Effectiveness Research for Two Medical Home Models for Attention Deficit Hyperactivity DisorderActive, not recruitingNo Results AvailableAttention Deficit/Hyperactivity DisorderBehavioral: Collaborative Care Plus|Behavioral: Traditional Collaborative Carehttps://ClinicalTrials.gov/show/NCT01275378
9858798587Optimizing Protein Intake in Older Americans With Mobility LimitationsRecruitingNo Results AvailableMobility LimitationDrug: Testosterone enanthate|Drug: Testosterone enanthatehttps://ClinicalTrials.gov/show/NCT01275365
9858898588CLCNKA (Ka Renal Chloride Channel[ClC-Ka]) Polymorphism Effects on Hypertrophy RegressionWithdrawnNo Results AvailableHypertensionDrug: Eplerenone|Drug: placebohttps://ClinicalTrials.gov/show/NCT01275352
9858998589Aortic Stenosis and PhosphodiEsterase Type 5 iNhibition (ASPEN): A Pilot StudyRecruitingNo Results AvailableAortic Stenosis|LV Remodeling, HypertrophyDrug: Tadalafil|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01275339
9859098590Indoor Air Quality and Infectious Aerosols in Health Care FacilitiesCompletedNo Results AvailableIndoor Air Quality|Infectious Aerosolshttps://ClinicalTrials.gov/show/NCT01275326
9859198591Trial on Wheeled Mobility for Preventing Pressure UlcersRecruitingNo Results AvailableMobility LimitationDevice: Lightweight wheelchair|Device: Skin Protection Cushionhttps://ClinicalTrials.gov/show/NCT01275313
9859298592Biosynthesis of PGD2 in VivoCompletedNo Results AvailableHealthy VolunteerDietary Supplement: 5 days of placebo followed by 600mg niacin|Dietary Supplement: aspirin first|Drug: 81 mg Aspirin|Dietary Supplement: Niaspan|Drug: Celebrex and niacinhttps://ClinicalTrials.gov/show/NCT01275300
9859398593Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - EculizumabWithdrawnNo Results AvailableAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisDrug: Standard of care treatment|Drug: eculizumabhttps://ClinicalTrials.gov/show/NCT01275287
9859498594Retinoids in ANCA Small Vessel Vasculitis: Silencing AutoantigensWithdrawnNo Results AvailableAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisDrug: Retinoic acid|Drug: Standard of carehttps://ClinicalTrials.gov/show/NCT01275274
9859598595Pilot Study of Avoidance of Bladder Catheters in Stroke Patients to Avoid Urinary Tract InfectionsTerminatedNo Results AvailableStroke|Catheter Associated Urinary Tract InfectionBehavioral: Nursing protocol to avoid Foley catheter placementhttps://ClinicalTrials.gov/show/NCT01275261
9859698596Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive DisorderTerminatedNo Results AvailableObsessive-compulsive DisorderDrug: Ondansetron|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01275248
9859798597Exposure to Type II Diabetes for Two Siblings With the Same ParentsCompletedNo Results AvailableType 2 Diabetes Mellitushttps://ClinicalTrials.gov/show/NCT01275235
9859898598Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal TumorsCompletedNo Results AvailableGastrointestinal Stromal TumorsDrug: Everolimus + Imatinibhttps://ClinicalTrials.gov/show/NCT01275222
9859998599Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Rituximab-refractory Follicular LymphomaCompletedNo Results AvailableFollicular LymphomaDrug: HCD122https://ClinicalTrials.gov/show/NCT01275209
9860098600Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP PatientsCompletedNo Results AvailableChronic Myeloid LeukemiaDrug: Nilotinib|Drug: Imatinibhttps://ClinicalTrials.gov/show/NCT01275196
9860198601Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and NeckCompletedNo Results AvailableHead and Neck CancerDrug: raltegravir and cisplatinhttps://ClinicalTrials.gov/show/NCT01275183
9860298602A Single-Dose Study to Investigate the Pharmacokinetics of MK-7655 in Participants With Impaired Renal Function (MK-7655-005 AM1)CompletedNo Results AvailableInfectious DiseaseDrug: MK-7655|Drug: imipenem + cilastatin|Drug: caffeine|Drug: midazolam|Drug: omeprazolehttps://ClinicalTrials.gov/show/NCT01275170
9860398603Disposition of 14C-LY2452473 Following Oral Administration in Healthy Human SubjectsCompletedNo Results AvailableHealthy VolunteersDrug: LY2452473https://ClinicalTrials.gov/show/NCT01275157
9860498604A Study of the Effect of LY2216684 on LorazepamCompletedNo Results AvailableMajor Depressive DisorderDrug: LY2216684|Drug: Placebo|Drug: Lorazepamhttps://ClinicalTrials.gov/show/NCT01275144
9860598605Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM)CompletedHas ResultsType 1 Diabetes MellitusDrug: Insulin aspart|Drug: Recombinant human hyaluronidase PH20 (rHuPH20)https://ClinicalTrials.gov/show/NCT01275131
9860698606Comparison of Postoperative Visual Acuity and Spectacle Independence Between the Tecnis Multifocal Intraoculer Lens (IOL) and the Crystalens Accommodating IOLCompletedNo Results AvailableCataractDevice: Tecnis Multifocal IOL|Device: crystalens Accommodating IOLhttps://ClinicalTrials.gov/show/NCT01275118
9860798607A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)CompletedNo Results AvailableAllergic ConjunctivitisDrug: Vehicle|Drug: Brimonidine Tartrate 0.01%|Drug: Brimonidine Tartrate 0.025%|Drug: Oxymetazoline HCl 0.025%https://ClinicalTrials.gov/show/NCT01275105
9860898608Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)CompletedHas ResultsCoronary Artery Disease|Coronary Disease|Myocardial Ischemia|Heart Diseases|Cardiovascular Diseases|Arteriosclerosis|Arterial Occlusive Diseases|Vascular DiseasesDevice: CorPath robotic-assisted PCIhttps://ClinicalTrials.gov/show/NCT01275092
9860998609Change of Nasalance After Tonsillectomy in Thai AdultRecruitingNo Results AvailableVoice Quality|Tonsillectomyhttps://ClinicalTrials.gov/show/NCT01275079
9861098610A Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)CompletedHas ResultsMPS IV ADrug: BMN 110 Weekly|Drug: Placebo|Drug: BMN 110 Every Other Weekhttps://ClinicalTrials.gov/show/NCT01275066

* Görseller ve İçerik tekif hakkına sahip olabilir